Packaging Of America Highlights Eco Barrier Technology for Sustainable Pharmaceutical Solutions at Pharmapack 2026
- LOG Pharma will reveal its Eco barrier technology at Pharmapack Europe 2026, emphasizing innovation in pharmaceutical packaging.
- The Eco barrier reduces packaging weight by 30% and costs by over 50%, enhancing sustainability and cost efficiency.
- LOG Pharma is committed to practical sustainability and leading advancements in environmentally responsible pharmaceutical packaging solutions.
Innovative Sustainable Solutions in Pharmaceutical Packaging: A Spotlight on Eco Barrier Technology
LOG Pharma Primary Packaging is set to unveil its groundbreaking Eco barrier technology at Pharmapack Europe 2026, taking place on January 21-22 in Paris, France. This event serves as a significant platform for pharmaceutical packaging innovations, and the Eco barrier has been chosen for the Pharmapack Product Spotlight Gallery, underscoring its potential to revolutionize the industry. The Eco barrier, developed using Dow HEALTH+ pharma grade resins, offers an exceptional moisture and oxygen barrier, a critical factor for maintaining the integrity of pharmaceutical products. The technology not only ensures product safety but also reduces packaging weight by up to 30% compared to traditional bottles.
The implications of the Eco barrier extend beyond mere performance enhancements. By cutting down material usage, this innovative packaging solution contributes significantly to environmental sustainability. Pharmaceutical companies can benefit from more than just a reduction in their environmental footprint; they can also achieve substantial cost savings—over 50% in bottle costs. This dual advantage of cost efficiency and sustainability positions the Eco barrier as a strategic asset for pharmaceutical firms aiming to streamline their operations while adhering to eco-friendly practices. Furthermore, with approximately 90% of active pharmaceutical ingredients (APIs) being sensitive to moisture, the Eco barrier presents a critical solution that addresses a prevalent issue in the industry.
LOG Pharma, backed by over 50 years of experience in the global pharmaceutical arena and its manufacturing facilities in Israel and Hungary, emphasizes its commitment to advancing the industry through practical sustainability. Noam Nahari, VP of Marketing and Business Development at LOG Pharma, articulates the company's vision: “Eco represents our commitment to practical sustainability.” This commitment reflects a broader trend in the pharmaceutical packaging sector, where companies increasingly prioritize solutions that balance performance with environmental responsibility. For those interested in exploring this innovative technology further, LOG Pharma invites attendees to arrange meetings during the Pharmapack event.
Related Cashu News

Quaker Houghton Expands Operations in China to Boost Manufacturing and Market Presence
Quaker Houghton (Ticker: KWR) is advancing its operational footprint with the opening of a new manufacturing facility in Zhangjiagang, China, alongside the expansion of its laboratory in Shanghai. The…

FMC Corporation Partners with Tessenderlo Group to Enhance Market Position and Innovation
FMC Corporation (Ticker: FMC) announces a significant strategic maneuver as it makes strides in enhancing its market positioning through a prominent investment from Tessenderlo Group. This partnership…

International Paper Restructures Operations, Closes Four Plants for Enhanced Efficiency and Sustainability
International Paper Company (Ticker: IP) actively reshapes its operational strategy to enhance efficiency and sustainability within its North American network. The company announces significant change…

Air Products Shifts Focus to Renewable Ammonia Post Project Cancellations and Financial Setbacks
Air Products & Chemicals (Ticker: APD) pivots towards renewable ammonia amidst project cancellations. Air Products Scraps Louisiana Clean Energy Complex The company announces it will not continue with…

